ACE and leukemia: Studies are underway which will evaluate the time-dependent changes in cardiac function and examine the effect of an ACE-inhibitor on myocardial performance, mainly in children with different types of leukaemia and lymphomas (Singh et al, 1999; Silber et al, 2004; Lipshultz et al, 2005).